-
公开(公告)号:US11033511B2
公开(公告)日:2021-06-15
申请号:US16610955
申请日:2018-07-30
Applicant: HISAMITSU PHARMACEUTICAL CO., INC.
Inventor: Akira Shuto , Takao Kurokawa , Junya Horiuchi , Hidekazu Kuma , Satoshi Amano
IPC: A61K9/70 , A61K31/216
Abstract: The present invention provides a patch comprising a backing, and an adhesive layer on the backing, wherein the adhesive layer contains at least one drug selected from the group consisting of oxybutynin and a pharmaceutically acceptable salt thereof, a pressure-sensitive adhesive base, and diflucortolone valerate, and the content of the diflucortolone valerate is 0.0007 to 0.05% by mass based on the total mass of the adhesive layer.
-
公开(公告)号:US11607394B2
公开(公告)日:2023-03-21
申请号:US16954627
申请日:2018-12-14
Applicant: HISAMITSU PHARMACEUTICAL CO., INC.
Inventor: Hiroyuki Araki , Yuka Takagi , Yoko Fujiwara , Hiroaki Kobayashi , Takao Kurokawa
IPC: A61P25/16 , A61K47/32 , A61K31/381 , A61K9/70
Abstract: The present invention provides a rotigotine-containing patch comprising: a backing layer; and an adhesive agent layer, wherein the adhesive agent layer contains rotigotine and/or a pharmaceutically acceptable salt thereof,
the adhesive agent layer further contains a styrene-based thermoplastic elastomer, a petroleum-based resin and/or a terpene-based resin, an aliphatic alcohol, and a cross-linked polyvinylpyrrolidone, and
in the adhesive agent layer, a mass ratio of a content of the rotigotine and/or the pharmaceutically acceptable salt thereof in terms of rotigotine free form and a content of the cross-linked polyvinylpyrrolidone (content of the rotigotine and/or the pharmaceutically acceptable salt thereof in terms of rotigotine free form:content of the cross-linked polyvinylpyrrolidone) is 10:3 to 1:3.-
公开(公告)号:US12151030B2
公开(公告)日:2024-11-26
申请号:US17426796
申请日:2020-01-30
Applicant: HISAMITSU PHARMACEUTICAL CO., INC.
Inventor: Takao Kurokawa , Hidekazu Kuma , Masaki Yukuhiro
IPC: A61K9/70 , A61K31/13 , A61K31/27 , A61K31/381 , A61K31/403 , A61K31/407 , A61K31/4422 , A61K31/573
Abstract: The present invention provides a patch comprising an adhesive layer on a backing, wherein the adhesive layer contains a adhesive base, a skin irritant drug or a pharmaceutically acceptable salt thereof, and diflucortolone valerate, and the content of the diflucortolone valerate is 0.0009 to 0.08% by mass based on the total mass of the adhesive layer.
-
-